Salmeterol/fluticasone propionate (50/250 µg) combination is superior to double dose fluticasone (500 µg) for the treatment of symptomatic moderate asthma

Lignende værker

• Salmeterol/fluticasone propionate (50/250 µg) combination is superior to double dose fluticasone (500 µg) for the treatment of symptomatic moderate asthma
  af: K-C Bergmann, et al.
  Udgivet: (2004-01-01)
• Novel Fluticasone Propionate and Salmeterol Fixed-Dose Combination Nano-Encapsulated Particles Using Polyamide Based on L-Lysine
  af: Mohammad H. Alyami, et al.
  Udgivet: (2022-03-01)
• Microencapsulation of Fluticasone Propionate and Salmeterol Xinafoate in Modified Chitosan Microparticles for Release Optimization
  af: Nina Maria Ainali, et al.
  Udgivet: (2020-08-01)
• The Efficacy, Tolerance and Acceptance of a New Fixed-Dose Salmeterol and Fluticasone Propionate Dry-Powder Inhaler—Salflumix Easyhaler^® in COPD Patients in the Daily Clinical Practice
  af: Zbigniew Doniec, et al.
  Udgivet: (2022-11-01)
• Development of Novel Fluticasone/Salmeterol/Tiotropium-Loaded Dry Powder Inhaler and Bioequivalence Assessment to Commercial Products in Rats
  af: Hyukjun Cho, et al.
  Udgivet: (2025-01-01)